Format

Send to

Choose Destination
Adv Drug Deliv Rev. 2003 Jun 16;55(6):703-16.

Mechanisms of nuclear transport and interventions.

Author information

1
Division of Pulmonary and Critical Care Medicine, Feinberg School of Medicine, Northwestern University, 303 E. Chicago Ave., Tarry 14-707, Chicago, IL 60611, USA.

Abstract

One of the more overlooked aspects of drug action and delivery is the exploitation of nucleocytoplasmic shuttling. Eukaryotic cells regulate many biological processes by the compartmentation of specific proteins into designated areas. Drugs that have a direct effect on a single protein must be able to localize to the same site as the protein and interact with one or more of its domains. Alternatively, a drug that effectively blocks the target protein from reaching its proper organelle can also inhibit the protein's function. Exploiting the selective movement of macromolecules across the nuclear envelope represents an exciting new area of drug development. This review aims to explain the basic nuclear import/export pathways while focusing on the known drugs that alter the regulation of nucleocytoplasmic trafficking.

PMID:
12788535
DOI:
10.1016/s0169-409x(03)00048-6
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center